We protect your health through science

Investigación

Neisseria, Listeria and Bordetella

Líneas de investigación

Content with Investigacion Neisseria, Listeria y Bordetella .

Neisseria, Listeria y Bordetella

null

Custom

Publicaciones destacadas

Category
Sort

Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis

2. Abad R, Médina V, Fariñas MC, Martinez-Martinez L, Bambini S, Dari A, Medini D, Pizza M, Vázquez J. “Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis”. J Infect. 2017 Dec:75(6):511-520.

PUBMED DOI

Early evidence of expanding W ST-11 CC meningococcal incidence in Spain

3. Abad R, Vázquez JA “Early evidence of expanding W ST-11 CC meningococcal incidence in Spain.” J Infect. 2016 Sep;73(3):296-7.

PUBMED DOI

WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014

4. Jacobsson S, Golparian D, Cole M, Spiteri G, Martin I, Bergheim T, Borrego MJ, Crowley B, Crucitti T, Van Dam AP, Hoffmann S, Jeverica S, Kohl P, Mlynarczyk-Bonikowska B, Pakarna G, Stary A, Stefanelli P, Pavlik P, Tzelepi E, Abad R, Harris SR, Unemo M. “WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014.” J. Antimicrob. Chemother. (2016) 71 (11): 3109-3116.

PUBMED DOI

Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countrie

5. Abad R, Medina V, Stella M, Boccadifuoco G, Comanducci M, Bambini S, Muzzi A, Vázquez JA. “Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries.” PLoS One. 2016 Mar 7;11(3):e0150721.

PUBMED DOI

A large portion of MATS negative meningococcal strains from Spain are killed by sera from adolescents and infants immunized with 4CMenB

6. Abad R, Biolchi A, Moschioni M, Giuliani MM, Pizza M, Vázquez JA. “A large portion of MATS negative meningococcal strains from Spain are killed by sera from adolescents and infants immunized with 4CMenB”. Clin Vaccine Immunol. 2015 April; 22(4): 357-60.

PUBMED DOI

Serogroup W meningococcal disease: global spread and currently affecting the southern cone in Latin America

7. Abad R, López EL, Debbag R, Vázquez JA. “Serogroup W meningococcal disease: global spread and currently affecting the southern cone in Latin America”. Epidemiol Infect. 2014 Dec; 142(12): 2461-2470.

PUBMED DOI

Effectiveness of meningococcal serogroup C vaccine programme

8. Borrow R, Abad R, Trotter C, van der Klis FRM, Vázquez JA. “Effectiveness of meningococcal serogroup C vaccine programmes”. Vaccine. 2013 Sept 23; 31 (41): 4477-4486.

PUBMED DOI

Target Gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin

9. E. Hong, S.T. Hedberg, R. Abad, C. Fazio, R. Enríquez, A-E. Deghmane, K.A. Jolley, P. Stefanelli, M. Unemo, J.A. Vázquez, F.J. Veyrier, M.K. Taha. “Target Gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin”. Antimicrob Agents Chemoter 2013 April; 57 (4): 1961-1964.

PUBMED DOI

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessmen

U. Voguel, M.K. Taha, J.A. Vázquez, J. Findlow, H. Claus, P. Stefanelli, D.A. Caugant, P. Kriz, R. Abad, S. Bambini, A. Carannante, A.E. Deghmane, C. Fazio, M. Frosch, G. Frosi, S. Gilchrist, M.M. Giulani, E. Hong, M. Ledroit, P.G. Lovaglio, J. Lucidarme, M. Musilek, A. Muzzi, J. Oksne, F. Rigat, L. Orlandi, M. Stella, D. Thompson, M. Pizza, R. Rappuoli, D. Serruto, M. Comanducci, G. Boccadifuoco, J.J. Donnely, D. Medini, R. Borrow. “Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment”. Lancet Infect Dis. 2013 May; 13(5): 416-25.

PUBMED DOI

Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey

Harris SR, Cole MJ, Spiteri G, Sánchez-Busó L, Golparian D, Jacobsson S, Goater R, Abudahab K, Yeats CA, Bercot B, Borrego MJ, Crowley B, Stefanelli P, Tripodo F, Abad R, Aanensen DM, Unemo M, Euro-GASP study group. “Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe”. Lancet Infect Dis. 2018 Jul; 18(7):758-768.

PUBMED DOI

Content with Investigacion Neisseria, Listeria y Bordetella .

List of staff

Información adicional

The Neisseria, Listeria and Bordetella Unit provides support to the National Health System with the aim of improving the health and well-being of citizens, through the development and application of diagnostic and molecular characterization techniques, generating laboratory data essential for the surveillance of infectious diseases covered by the Unit, as well as maintaining lines of research for microbiological and immunological evaluation of vaccines, both in development and those available. 

The Unit has 4 microbiological surveillance programs at the National Center for Microbiology: For invasive meningococcal disease, for gonococcal infection, for listeriosis and for whooping cough. Likewise, the Unit maintains extensive activity in international networks and consortia: it is part of the EU-Ibis consortium for the study of Meningococcal Disease, the EURO-GASP program for the study of antibiotic resistance in gonococcus, the European Listeria typing group network and the European network for Bordetella, all of them coordinated and financed in whole or in part by the ECDC.  

The Unit constitutes the External Reference Laboratory for meningococci of the PAHO/WHO SIREVAII network. Thus, the active lines of research in the Unit respond to the objectives defined both by the support for the National Health System and by the international collaborative work in which it actively participates.

Content with Investigacion Neisseria, Listeria y Bordetella .